Correction to: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth (Breast Cancer Research, (2024), 26, 1, (23), 10.1186/s13058-024-01778-w)

Jing Qian, Yanxia Ma, William M. Tahaney, Cassandra L. Moyer, Amanda Lanier, Jamal Hill, Darian Coleman, Negar Koupaei, Susan G. Hilsenbeck, Michelle I. Savage, Brent D.G. Page, Abhijit Mazumdar, Powel H. Brown

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original article has incomplete funding information with regard to author Negar Koupaei. The complete funding note is as follows: This work was funded by a Susan G Komen Promise Grant (KG081694 P.H.B.), a Komen SAB Grant (9SAB12-00006, P.H.B.), and a CCSG Grant (P30 CA016672, P.H.B.). This work was also supported by the John Charles Cain Endowment (P.H.B.). Negar Koupaei (NK) was supported by the 1R25CA240137-01A1 UPWARDS Training Program and by the CPRIT Research Training Award CPRIT Training Program (RP210028). The original article [1] has been corrected.

Original languageEnglish (US)
Article number53
JournalBreast Cancer Research
Volume26
Issue number1
DOIs
StatePublished - Dec 2024

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth (Breast Cancer Research, (2024), 26, 1, (23), 10.1186/s13058-024-01778-w)'. Together they form a unique fingerprint.

Cite this